Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Tedizolid (TR-701): a new oxazolidinone with enhanced potency.

Kanafani ZA, Corey GR.

Expert Opin Investig Drugs. 2012 Apr;21(4):515-22. doi: 10.1517/13543784.2012.660250. Epub 2012 Feb 13. Review.

PMID:
22324973
2.

Tedizolid: a new oxazolidinone antimicrobial.

Kisgen JJ, Mansour H, Unger NR, Childs LM.

Am J Health Syst Pharm. 2014 Apr 15;71(8):621-33. doi: 10.2146/ajhp130482. Review.

PMID:
24688035
3.

Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.

Zhanel GG, Love R, Adam H, Golden A, Zelenitsky S, Schweizer F, Gorityala B, Lagacé-Wiens PR, Rubinstein E, Walkty A, Gin AS, Gilmour M, Hoban DJ, Lynch JP 3rd, Karlowsky JA.

Drugs. 2015 Feb;75(3):253-70. doi: 10.1007/s40265-015-0352-7. Review.

PMID:
25673021
4.

Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model.

Keel RA, Tessier PR, Crandon JL, Nicolau DP.

Antimicrob Agents Chemother. 2012 Aug;56(8):4403-7. doi: 10.1128/AAC.00122-12. Epub 2012 Jun 11.

5.
6.

In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci.

Rodríguez-Avial I, Culebras E, Betriu C, Morales G, Pena I, Picazo JJ.

J Antimicrob Chemother. 2012 Jan;67(1):167-9. doi: 10.1093/jac/dkr403. Epub 2011 Sep 27.

PMID:
21954458
7.

Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.

Douros A, Grabowski K, Stahlmann R.

Expert Opin Drug Metab Toxicol. 2015;11(12):1849-59. doi: 10.1517/17425255.2015.1098617. Epub 2015 Oct 12. Review. Erratum in: Expert Opin Drug Metab Toxicol. 2015;11(12):v.

PMID:
26457865
8.

Oxazolidinone antibiotics.

Diekema DJ, Jones RN.

Lancet. 2001 Dec 8;358(9297):1975-82. Review.

PMID:
11747939
9.
10.

Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.

Rybak JM, Marx K, Martin CA.

Pharmacotherapy. 2014 Nov;34(11):1198-208. doi: 10.1002/phar.1491. Epub 2014 Sep 30. Review.

PMID:
25266820
11.

Linezolid--a review of the first oxazolidinone.

Norrby R.

Expert Opin Pharmacother. 2001 Feb;2(2):293-302. Review.

PMID:
11336587
12.

The oxazolidinones as a new family of antimicrobial agent.

Marchese A, Schito GC.

Clin Microbiol Infect. 2001;7 Suppl 4:66-74. Review.

13.

Platelet profile in patients with acute bacterial skin and skin structure infections receiving tedizolid or linezolid: findings from the Phase 3 ESTABLISH clinical trials.

Lodise TP, Fang E, Minassian SL, Prokocimer PG.

Antimicrob Agents Chemother. 2014 Dec;58(12):7198-204. doi: 10.1128/AAC.03509-14. Epub 2014 Sep 22.

14.

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.

Urbina O, Ferrández O, Espona M, Salas E, Ferrández I, Grau S.

Drug Des Devel Ther. 2013 Apr 3;7:243-65. doi: 10.2147/DDDT.S30728. Print 2013. Review.

15.

Tedizolid: a novel oxazolidinone for Gram-positive infections.

Moellering RC Jr.

Clin Infect Dis. 2014 Jan;58 Suppl 1:S1-3. doi: 10.1093/cid/cit658. Review. No abstract available.

PMID:
24343826
16.

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.

Shorr AF, Lodise TP, Corey GR, De Anda C, Fang E, Das AF, Prokocimer P.

Antimicrob Agents Chemother. 2015 Feb;59(2):864-71. doi: 10.1128/AAC.03688-14. Epub 2014 Nov 24.

17.

Tedizolid for the management of human infections: in vitro characteristics.

Locke JB, Zurenko GE, Shaw KJ, Bartizal K.

Clin Infect Dis. 2014 Jan;58 Suppl 1:S35-42. doi: 10.1093/cid/cit616. Review.

PMID:
24343830
18.

Linezolid.

Narang M, Gomber S.

Indian Pediatr. 2004 Nov;41(11):1129-32.

19.

Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.

McBride D, Krekel T, Hsueh K, Durkin MJ.

Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):331-337. doi: 10.1080/17425255.2017.1290080. Epub 2017 Feb 16. Review.

PMID:
28140693
20.

Oxazolidinone antimicrobials: a patent review (2012-2015).

Phillips OA, Sharaf LH.

Expert Opin Ther Pat. 2016 May;26(5):591-605. doi: 10.1517/13543776.2016.1168807. Epub 2016 Apr 4. Review.

PMID:
26998627

Supplemental Content

Support Center